Clinical Trial Update: The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated tegaserod therapy for managing dyspeptic symptoms in female patients on proton pump inhibitors for heartburn; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Tegaserod (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Dyspepsia | Phase 3 | Status: COMPLETED